Search Results - "Tadej Pajič"

Refine Results
  1. 1

    Testing for Factor V Leiden (FVL) and Prothrombin G20210A Genetic Variants by Pajič, Tadej

    “…Laboratory testing for Factor V Leiden and Prothrombin G20210A genetic variants permits defining the increased relative risk for venous thromboembolism in…”
    Get more information
    Journal Article
  2. 2

    MUTATIONAL STATUS of REARRANGED IMMUNOGLOBULIN HEAVY CHAIN VARIABLE Genes in a COHORT of SLOVENIAN PATIENTS with CHRONIC LYMPHOCYTIC LEUKAEMIA by Pajič, Tadej, Maleŝiĉ, Ivan, Zver, Samo, Ĉernelĉ, Peter

    Published in Blood (20-11-2009)
    “…Abstract 4399 The aims of the study were to determine the mutational status and IGHV gene usage in our cohort of patients with B-CLL and compare the results to…”
    Get full text
    Journal Article
  3. 3

    The Contemporary Approach to CALR-Positive Myeloproliferative Neoplasms by Belčič Mikič, Tanja, Pajič, Tadej, Zver, Samo, Sever, Matjaž

    “…mutations are a revolutionary discovery and represent an important hallmark of myeloproliferative neoplasms (MPN), especially essential thrombocythemia and…”
    Get full text
    Journal Article
  4. 4

    Improved survival of AML patients by addition of cladribine to standard induction chemotherapy by Anžej Doma, Saša, Škerget, Matevž, Pajič, Tadej, Sever, Matjaž

    Published in Annals of hematology (01-03-2020)
    “…One hundred and eight consecutive acute myeloid leukemia (AML) patients aged 60 or less treated with two different induction regimens were retrospectively…”
    Get full text
    Journal Article
  5. 5

    Simultaneous measurement of imatinib, nilotinib and dasatinib in dried blood spot by ultra high performance liquid chromatography tandem mass spectrometry by Kralj, Eva, Trontelj, Jurij, Pajič, Tadej, Kristl, Albin

    “…► Therapeutic drug monitoring is beneficial whilst using tyrosine kinase inhibitors. ► Dried blood spot (DBS) is a simple and less invasive blood sampling…”
    Get full text
    Journal Article
  6. 6

    Factor V Leiden and FII 20210 testing in thromboembolic disorders by Pajič, Tadej

    Published in Clinical chemistry and laboratory medicine (01-12-2010)
    “…Factor V Leiden and prothrombin (F2) c.20210G>A mutation detection are very important in order to define the increased relative risk for venous thromboembolism…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9

    Opredelitev eritrocitoz in predlog diagnostičnega algoritma v Sloveniji by Debeljak, Nataša, Lazarevič, Julija, Miskič, Dejan, Vermiglio, Lucija, Kopitar, Anja, Solarovič, Anja, Sever, Matjaž, Fink, Martina, Pajič, Tadej, Anžej Doma, Saša, Moškon, Miha, Preložnik Zupan, Irena

    “…Eritrocitoza je stanje s povečano maso eritrocitov v telesu. Odrazi se s povečanim hematokritom, zvečano koncentracijo hemoglobina in povečanim številom…”
    Get full text
    Journal Article
  10. 10

    Utility of next-generation sequencing in identifying congenital erythrocytosis in patients with idiopathic erythrocytosis by Anžej Doma, Saša, Kraljić, Nika, Kristan, Aleša, Debeljak, Nataša, Maver, Aleš, Pajič, Tadej, Preložnik Zupan, Irena

    Published in Frontiers in medicine (06-09-2024)
    “…Congenital erythrocytosis (CE) is increasingly recognized as the cause of erythrocytosis in patients in whom polycythemia vera and secondary acquired causes…”
    Get full text
    Journal Article
  11. 11

    Genetic Variant Detection in the CALR gene using High Resolution Melting Analysis by Pajič, Tadej, Belčič Mikič, Tanja, Podgornik, Helena, Klun, Jurka, Šućurović, Sandra, Zver, Samo, Sever, Matjaz

    Published in Journal of visualized experiments (26-08-2020)
    “…High resolution melting analysis (HRM) is a powerful method for genotyping and genetic variation scanning. Most HRM applications depend on saturating DNA dyes…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Is It Possible to Predict Clonal Thrombocytosis in Triple-Negative Patients with Isolated Thrombocytosis Based Only on Clinical or Blood Findings? by Belčič Mikič, Tanja, Vratanar, Bor, Pajič, Tadej, Anžej Doma, Saša, Debeljak, Nataša, Preložnik Zupan, Irena, Sever, Matjaž, Zver, Samo

    Published in Journal of clinical medicine (11-12-2021)
    “…, and mutations define clonal thrombocytosis in about 90% of patients with sustained isolated thrombocytosis. In the remainder of patients (triple-negative…”
    Get full text
    Journal Article
  14. 14

    Concurrent acquired inhibitors to factor VIII and IX, a laboratory artifact: a case report by Doma, Saša Anžej, Hillarp, Andreas, Pajič, Tadej, Andoljšek, Dušan, Černelč, Peter, Preldžnik Zupan, Irena

    Published in Biochemia medica (01-01-2016)
    “…Acquired inhibitors to coagulation factors other than factor VIII are extremely rare. We describe a case of a 59-year-old woman with abnormal bleeding,…”
    Get full text
    Journal Article
  15. 15

    Monitoring of imatinib targeted delivery in human leukocytes by Kralj, Eva, Žakelj, Simon, Trontelj, Jurij, Pajič, Tadej, Preložnik Zupan, Irena, Černelč, Peter, Ostanek, Barbara, Marc, Janja, Kristl, Albin

    “…[Display omitted] The success of imatinib therapy in chronic myeloid leukemia is highly influenced by its active transport into target cells. However, the…”
    Get full text
    Journal Article
  16. 16

    Glutamate dehydrogenase activity in lymphocytes of B-cell chronic lymphocytic leukaemia patients by Pajič, Tadej, Černelč, Peter, Sešek Briški, Alenka, Lejko-Zupanc, Tatjana, Malešič, Ivan

    Published in Clinical biochemistry (01-11-2009)
    “…Objectives: To investigate the pattern of glutamate dehydrogenase (GLDH) activity, GLUD1 and GLUD2 expressions in peripheral blood mononuclear cells (PBMC) of…”
    Get full text
    Journal Article
  17. 17

    The thrombopoietin receptor W515L and W515k mutations detection in patients with essential thrombocythemia by Pajic, Tadej, Kovacic, Leonida, Mlakar, Uros

    “…Background: The aim of the study was to investigate the frequency of the thrombopoietin receptor (MPL) W515L and W515K mutations in our cohort of essential…”
    Get full text
    Journal Article
  18. 18

    Determination of D816V mutation in the c-kIt gene in the Slovenian patients with acute myeloid leukemia and systemic mastocytosis by Fink, Martina, Cernelc, Peter, Pajic, Tadej

    “…Background: D816V mutation in the C-KIT gene is present in more than 90 % of patients with systemic mastocytosis (SM) and 2-7 % of patients with acute myeloid…”
    Get full text
    Journal Article
  19. 19

    Slovenska priporočila za obravnavo kronične mieloične levkemije by Preložnik Zupan, Irena, Rener, Karla, Podgornik, Helena, Sever, Matjaž, Fink, Martina, Grat, Mateja, Pajič, Tadej

    “…The paper presents recommendations for the management of patients with chronic myeloid leukaemia. Clinical manifestations, diagnostics, treatment and…”
    Get full text
    Journal Article
  20. 20

    Risk factors for thromboembolic events in children and young adults by Kotnik, Barbara Faganel, Kitanovski, Lidija, Pajic, Tadej, Dolnicar, Majda Benedik

    “…Background: Thromboembolic events (TEE) in children are rare. They develop through concomitant hemodynamic disturbances in the cardiovascular system or as a…”
    Get full text
    Journal Article